Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Boer, Y.S. de"'
Autor:
Snijders, R.J.A.L.M., Stoelinga, A.E.C., Gevers, T.J.G., Pape, S., Biewenga, M., Verdonk, R.C., Jonge, H.J.M. de, Vrolijk, J.M., Bakker, S.F., Vanwolleghem, T., Boer, Y.S. de, Pronk, M.A.M.C.B., Beuers, U.H.W., Meer, A.J. van der, Gerven, N.M.F. van, Sijtsma, M.G.M., Verwer, B.J., Gisbertz, I.A.M., Bartelink, M., Brand, F.F. van den, Korkmaz, K.S., Berg, A.P. van den, Guichelaar, M.M.J., Soufidi, K., Levens, A.D., Hoek, B. van, Drenth, J.P.H., Dutch Autoimmune Hepatitis Working
Publikováno v:
Trials, 23(1):1012. BioMed Central Ltd.
Trials, 23(1):1012. BioMed Central
TRIALS, 23(1):1012. BMC
on behalf of the Dutch Autoimmune Hepatitis Working Group 2022, ' Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial) : study protocol for a randomised controlled trial ', Trials, vol. 23, no. 1, 1012 . https://doi.org/10.1186/s13063-022-06890-w
Trials
Trials, 23(1). BMC
Trials, 23, 1
Trials, 23(1). BioMed Central Ltd
Trials, 23
Trials, 23(1):1012. BioMed Central
TRIALS, 23(1):1012. BMC
on behalf of the Dutch Autoimmune Hepatitis Working Group 2022, ' Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial) : study protocol for a randomised controlled trial ', Trials, vol. 23, no. 1, 1012 . https://doi.org/10.1186/s13063-022-06890-w
Trials
Trials, 23(1). BMC
Trials, 23, 1
Trials, 23(1). BioMed Central Ltd
Trials, 23
Background Currently, the standard therapy for autoimmune hepatitis (AIH) consists of a combination of prednisolone and azathioprine. However, 15% of patients are intolerant to azathioprine which necessitates cessation of azathioprine or changes in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f268f0c5f0c5d471147b4cc9c9b0876
https://hdl.handle.net/1887/3564045
https://hdl.handle.net/1887/3564045
Autor:
Brand, F.F. van den, Veen, K.S. van der, Lissenberg-Witte, B.I., Boer, Y.S. de, Hoek, B. van, Drenth, J.P.H., Verdonk, R.C., Vrolijk, J.M., Nieuwkerk, C.M.J. van, Bouma, G., Gerven, N.M. van, Kuijvenhoven, J.P., Schreuder, T.C.M.A., Wouden, E.J. van der, Meyel, J.J.M. van, Baak, L.C., Stadhouders, P.H.G.M., Klemt-Kropp, M., Verhagen, M.A.M.T., Bhalla, A., Ouden, J.W. den, Beuers, U., Erpecum, K.J. van, Buuren, H.R. van, Brouwer, J.T., Dutch Autoimmune Hepatitis Study G
Publikováno v:
Alimentary Pharmacology & Therapeutics. Wiley
Alimentary Pharmacology & Therapeutics, 50, 1120-1126
Alimentary Pharmacology & Therapeutics, 50, 10, pp. 1120-1126
Alimentary Pharmacology & Therapeutics, 50(10), 1120-1126. Wiley-Blackwell Publishing Ltd
Alimentary Pharmacology and Therapeutics, 50(10), 1120-1126
van den Brand, F F, van der Veen, K S, Lissenberg-Witte, B I, de Boer, Y S, van Hoek, B, Drenth, J P H, Verdonk, R C, Vrolijk, J M, van Nieuwkerk, C M J, Bouma, G & the Dutch Autoimmune Hepatitis Study Group 2019, ' Adverse events related to low dose corticosteroids in autoimmune hepatitis ', Alimentary Pharmacology and Therapeutics, vol. 50, no. 10, pp. 1120-1126 . https://doi.org/10.1111/apt.15528
Alimentary pharmacology & therapeutics, 50(10), 1120-1126. Wiley-Blackwell
Alimentary Pharmacology & Therapeutics
Alimentary Pharmacology & Therapeutics, 50, 1120-1126
Alimentary Pharmacology & Therapeutics, 50, 10, pp. 1120-1126
Alimentary Pharmacology & Therapeutics, 50(10), 1120-1126. Wiley-Blackwell Publishing Ltd
Alimentary Pharmacology and Therapeutics, 50(10), 1120-1126
van den Brand, F F, van der Veen, K S, Lissenberg-Witte, B I, de Boer, Y S, van Hoek, B, Drenth, J P H, Verdonk, R C, Vrolijk, J M, van Nieuwkerk, C M J, Bouma, G & the Dutch Autoimmune Hepatitis Study Group 2019, ' Adverse events related to low dose corticosteroids in autoimmune hepatitis ', Alimentary Pharmacology and Therapeutics, vol. 50, no. 10, pp. 1120-1126 . https://doi.org/10.1111/apt.15528
Alimentary pharmacology & therapeutics, 50(10), 1120-1126. Wiley-Blackwell
Alimentary Pharmacology & Therapeutics
Contains fulltext : 215386.pdf (Publisher’s version ) (Open Access) BACKGROUND: Autoimmune hepatitis requires long-term therapy, and systemic corticosteroids are the backbone of therapeutic management. Prolonged use of corticosteroids may lead to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3163eba8675cb92e580487f40cf77564
https://research.rug.nl/en/publications/0b06aee2-a79e-4059-9bfc-519cb26c3f07
https://research.rug.nl/en/publications/0b06aee2-a79e-4059-9bfc-519cb26c3f07
Autor:
Gerven, N.M. van, Eijk, A.A. van der, Pas, S.D., Zaaijer, H.L., Boer, Y.S. de, Witte, B.I., Nieuwkerk, C.M. van, Mulder, C.J., Bouma, G., Man, R.A. de, Drenth, J.P.H.
Publikováno v:
Journal of Gastrointestinal and Liver Diseases, 25, 1, pp. 9-13
Journal of Gastrointestinal and Liver Diseases, 25, 9-13
Journal of Gastrointestinal and Liver Diseases, 25(1), 9-13. Romanian Society of Gastroenterology
Journal of Gastrointestinal and Liver Diseases, 25, 9-13
Journal of Gastrointestinal and Liver Diseases, 25(1), 9-13. Romanian Society of Gastroenterology
Background & Aims: In recent years chronic courses of hepatitis E virus (HEV) infection have been described in immunosuppressed individuals. This may implicate a potential role for HEV in the development of autoimmune diseases, including autoimmune h
HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1
Autor:
Gerven, N.M.F. van, Boer, Y.S. de, Zwiers, A., Verwer, B.J., Drenth, J.P.H., Hoek, B. van, Erpecum, K.J. van, Beuers, U., Buuren, H.R. van, Ouden, J.W. den, Verdonk, R.C., Koek, G.H., Brouwer, J.T., Guichelaar, M.J., Vrolijk, J.M., Coenraad, M.J., Kraal, G., Mulder, C.J.J., Nieuwkerk, C.M.J. van, Bloemena, E., Verspaget, H.W., Kumar, V., Zhernakova, A., Wijmenga, C., Franke, L., Bouma, G., Dutch Autoimmune Hepatitis Study G
Publikováno v:
Genes and Immunity, 16, 4, pp. 247-52
Genes and immunity, 16(4), 247-252. Nature Publishing Group
van Gerven, N M F, de Boer, Y S, Zwiers, A, Verwer, B J, Drenth, J P H, van Hoek, B, van Erpecum, K J, Beuers, U, van Buuren, H R, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M J, Vrolijk, J M, Coenraad, M J, Kraal, G, Mulder, C J J, van Nieuwkerk, C M J, Bloemena, E, Verspaget, H W, Kumar, V, Zhernakova, A, Wijmenga, C, Franke, L & Bouma, G 2015, ' HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1 ', Genes and Immunity, vol. 16, no. 4, pp. 247-252 . https://doi.org/10.1038/gene.2014.82
Genes and Immunity, 16(4), 247-252. Nature Publishing Group
Genes and Immunity, 16, 247-52
GENES AND IMMUNITY, 16(4), 247-252. Nature Publishing Group
Genes and Immunity, 16(4), 247-252
Genes and immunity, 16(4), 247-252. Nature Publishing Group
van Gerven, N M F, de Boer, Y S, Zwiers, A, Verwer, B J, Drenth, J P H, van Hoek, B, van Erpecum, K J, Beuers, U, van Buuren, H R, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M J, Vrolijk, J M, Coenraad, M J, Kraal, G, Mulder, C J J, van Nieuwkerk, C M J, Bloemena, E, Verspaget, H W, Kumar, V, Zhernakova, A, Wijmenga, C, Franke, L & Bouma, G 2015, ' HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1 ', Genes and Immunity, vol. 16, no. 4, pp. 247-252 . https://doi.org/10.1038/gene.2014.82
Genes and Immunity, 16(4), 247-252. Nature Publishing Group
Genes and Immunity, 16, 247-52
GENES AND IMMUNITY, 16(4), 247-252. Nature Publishing Group
Genes and Immunity, 16(4), 247-252
The classical human leukocyte antigen (HLA)-DRB1*03:01 and HLA-DRB1*04:01 alleles are established autoimmune hepatitis (AIH) risk alleles. To study the immune-modifying effect of these alleles, we imputed the genotypes from genome-wide association da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18d771b0038901538160f49535c9a00d
https://hdl.handle.net/2066/155390
https://hdl.handle.net/2066/155390
Autor:
Boer, Y.S. de, Gerven, N.M.F. van, Zwiers, A., Verwer, B.J., Hoek, B. van, Erpecum, K.J. van, Beuers, U., Buuren, H.R. van, Drenth, J.P.H., Ouden, J.W. den, Verdonk, R.C., Koek, G.H., Brouwer, J.T., Guichelaar, M.M.J., Vrolijk, J.M., Kraal, G., Mulder, C.J.J., Nieuwkerk, C.M.J. van, Fischer, J., Berg, T., Stickel, F., Sarrazin, C., Schramm, C., Lohse, A.W., Weiler-Normann, C., Lerch, M.M., Nauck, M., Volzke, H., Homuth, G., Bloemena, E., Verspaget, H.W., Kumar, V., Zhernakova, A., Wijmenga, C., Franke, L., Bouma, G., Dutch Autoimmune Hepatitis Study, LifeLines Cohort Study, Study Hlth Pomerania
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10693::e43f23c2c7d0cb594160038dd58502d5
https://hdl.handle.net/1887/117557
https://hdl.handle.net/1887/117557
Autor:
Boer, Y.S. de, Gerven, N.M.F. van, Zwiers, A., Verwer, B.J., Hoek, B. van, Erpecum, K.J. van, Beuers, U., Buuren, H.R. van, Drenth, J.P.H., Ouden, J.W. den, Verdonk, R.C., Koek, G.H., Brouwer, J.T., Guichelaar, M.M.J., Vrolijk, J.M., Kraal, G., Mulder, C.J.J., Nieuwkerk, C.M.J. van, Fischer, J., Berg, T., Stickel, F., Sarrazin, C., Schramm, C., Lohse, A.W., Weiler-Normann, C., Lerch, M.M., Nauck, M., Volzke, H., Homuth, G., Bloemena, E., Verspaget, H.W., Kumar, V., Zhernakova, A., Wijmenga, C., Franke, L., Bouma, G., Dutch Autoimmune Hepatitis Study, LifeLines Cohort Study, Study Hlth Pomerania
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______202::e43f23c2c7d0cb594160038dd58502d5
https://hdl.handle.net/1887/117557
https://hdl.handle.net/1887/117557
Autor:
Boer, Y.S. de, Gerven, N.M. van, Verwer, B., Zwiers, A., Hoek, B. van, Erpecum, K.J. van, Beuers, U., Buuren, H.R. van, Drenth, J.P.H., Ouden, J.W. den, Verdonk, R.C., Koek, G.H., Brouwer, J.T., Guichelaar, M.M.J., Vrolijk, J.M., Kraal, G., Mulder, C.J.J., Nieuwkerk, C.M.J. van, Fischer, J., Berg, T., Stickel, F., Sarrazin, C., Schramm, C., Lohse, A.W., Weiler-Normann, C., Lerch, M.M., Nauck, M., Volzke, H., Homuth, G., Bloemena, E., Kumar, V., Zhernakova, A., Wijmenga, C., Franke, L., Bouma, G., Dutch Autoimmune Hepatitis Study G, LifeLines Cohort Study, Study Hlth Pomerania
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______202::6202e8c81b3a9c842e2dfe68a656e93e
https://hdl.handle.net/1887/101678
https://hdl.handle.net/1887/101678
Autor:
Boer, Y.S. de, Gerven, N.M. van, Verwer, B., Zwiers, A., Hoek, B. van, Erpecum, K.J. van, Beuers, U., Buuren, H.R. van, Drenth, J.P.H., Ouden, J.W. den, Verdonk, R.C., Koek, G.H., Brouwer, J.T., Guichelaar, M.M.J., Vrolijk, J.M., Kraal, G., Mulder, C.J.J., Nieuwkerk, C.M.J. van, Fischer, J., Berg, T., Stickel, F., Sarrazin, C., Schramm, C., Lohse, A.W., Weiler-Normann, C., Lerch, M.M., Nauck, M., Volzke, H., Homuth, G., Bloemena, E., Kumar, V., Zhernakova, A., Wijmenga, C., Franke, L., Bouma, G., Dutch Autoimmune Hepatitis Study G, LifeLines Cohort Study, Study Hlth Pomerania
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10693::6202e8c81b3a9c842e2dfe68a656e93e
https://hdl.handle.net/1887/101678
https://hdl.handle.net/1887/101678
Autor:
Boer, Y.S. de, Gerven, N.M.F. van, Zwiers, A., Verwer, B.J., Hoek, B. van, Erpecum, K.J. van, Beuers, U., Buuren, H.R. van, Drenth, J.P.H., Ouden, J.W. den, Verdonk, R.C., Koek, G.H., Brouwer, J.T., Guichelaar, M.M.J., Vrolijk, J.M., Kraal, G., Mulder, C.J.J., Nieuwkerk, C.M.J. van, Fischer, J., Berg, T., Stickel, F., Sarrazin, C., Schramm, C., Lohse, A.W., Weiler-Normann, C., Lerch, M.M., Nauck, M., Volzke, H., Homuth, G., Bloemena, E., Verspaget, H.W., Kumar, V., Zhernakova, A., Wijmenga, C., Franke, L., Bouma, G., Dutch Autoimmune Hepatitis Study, LifeLines Cohort Study, Study Hlth Pomerania
Publikováno v:
Gastroenterology, 147(2), 443-452. W.B. Saunders Ltd
Gastroenterology, 147(2). Elsevier Saunders
de Boer, Y S, van Gerven, N M F, Zwiers, A, Verwer, B J, van Hoek, B, van Erpecum, K J, Beuers, U, van Buuren, H R, Drenth, J P H, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M M J, Vrolijk, J M, Kraal, G, Mulder, C J J, van Nieuwkerk, C M J, Fischer, J, Berg, T, Stickel, F, Sarrazin, C, Schramm, C, Lohse, A W, Weiler-Normann, C, Lerch, M M, Nauck, M, Volzke, H, Homuth, G, Bloemena, E, Verspaget, H W, Kumar, V, Zhernakova, A, Wijmenga, C, Franke, L & Bouma, G 2014, ' Genome-wide association study identifies variants associated with autoimmune hepatitis type 1 ', Gastroenterology, vol. 147, no. 2, pp. 443-452 . https://doi.org/10.1053/j.gastro.2014.04.022
Gastroenterology, 147, 2, pp. 443-52 e5
Gastroenterology, 147(2), 443-452.e5. W B SAUNDERS CO-ELSEVIER INC
Gastroenterology, 147(2), 443-452. W.B. Saunders
Gastroenterology, 147, 443-52 e5
Gastroenterology, 147(2), 443-52.e5. W.B. Saunders Ltd
Gastroenterology, 147(2), 443
Gastroenterology, 147(2). Elsevier Saunders
de Boer, Y S, van Gerven, N M F, Zwiers, A, Verwer, B J, van Hoek, B, van Erpecum, K J, Beuers, U, van Buuren, H R, Drenth, J P H, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M M J, Vrolijk, J M, Kraal, G, Mulder, C J J, van Nieuwkerk, C M J, Fischer, J, Berg, T, Stickel, F, Sarrazin, C, Schramm, C, Lohse, A W, Weiler-Normann, C, Lerch, M M, Nauck, M, Volzke, H, Homuth, G, Bloemena, E, Verspaget, H W, Kumar, V, Zhernakova, A, Wijmenga, C, Franke, L & Bouma, G 2014, ' Genome-wide association study identifies variants associated with autoimmune hepatitis type 1 ', Gastroenterology, vol. 147, no. 2, pp. 443-452 . https://doi.org/10.1053/j.gastro.2014.04.022
Gastroenterology, 147, 2, pp. 443-52 e5
Gastroenterology, 147(2), 443-452.e5. W B SAUNDERS CO-ELSEVIER INC
Gastroenterology, 147(2), 443-452. W.B. Saunders
Gastroenterology, 147, 443-52 e5
Gastroenterology, 147(2), 443-52.e5. W.B. Saunders Ltd
Gastroenterology, 147(2), 443
Item does not contain fulltext BACKGROUND & AIMS: Autoimmune hepatitis (AIH) is an uncommon autoimmune liver disease of unknown etiology. We used a genome-wide approach to identify genetic variants that predispose individuals to AIH. METHODS: We perf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac3eddae90e7965c1c29b48a789d19fa
https://research.vumc.nl/en/publications/2e9a1d67-d5f1-4809-be6f-0c1a76118288
https://research.vumc.nl/en/publications/2e9a1d67-d5f1-4809-be6f-0c1a76118288
Autor:
Gerven, N.M.F. van, Boer, Y.S. de, Zwiers, A., Hoek, B. van, Erpecum, K.J. van, Beuers, U., Buuren, H.R. van, Drenth, J.P.H., Ouden, J.W. den, Verdonk, R.C., Koek, G.H., Brouwer, J.T., Guichelaar, M.M.J., Vrolijk, J.M., Kraal, G., Mulder, C.J.J., Nieuwkerk, C.M.J. van, Bouma, G., Dutch Autoimmune Hepatitis Study G
Publikováno v:
Liver International, 33, 1039-43
Liver International, 33(7), 1039-1043. Wiley
Liver International, 33(7), 1039-1043. Wiley-Blackwell Publishing Ltd
van Gerven, N M F, de Boer, Y S, Zwiers, A, van Hoek, B, van Erpecum, K J, Beuers, U, van Buuren, H R, Drenth, J P, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M M, Bloemena, E, Vrolijk, J M, Kraal, G, Mulder, C J J, van Nieuwkerk, C M J & Bouma, G 2013, ' Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis ', Liver International, vol. 33, no. 7, pp. 1039-1043 . https://doi.org/10.1111/liv.12157
Liver International, 33(7), 1039-1043
Liver International, 33(7), 1039-1043. Wiley-Blackwell
Liver international, 33(7), 1039-1043. Wiley-Blackwell
Liver International, 33, 7, pp. 1039-43
Liver International, 33(7), 1039-1043. Wiley
Liver International, 33(7), 1039-1043. Wiley-Blackwell Publishing Ltd
van Gerven, N M F, de Boer, Y S, Zwiers, A, van Hoek, B, van Erpecum, K J, Beuers, U, van Buuren, H R, Drenth, J P, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M M, Bloemena, E, Vrolijk, J M, Kraal, G, Mulder, C J J, van Nieuwkerk, C M J & Bouma, G 2013, ' Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis ', Liver International, vol. 33, no. 7, pp. 1039-1043 . https://doi.org/10.1111/liv.12157
Liver International, 33(7), 1039-1043
Liver International, 33(7), 1039-1043. Wiley-Blackwell
Liver international, 33(7), 1039-1043. Wiley-Blackwell
Liver International, 33, 7, pp. 1039-43
Background & AimsSingle nucleotide polymorphisms (SNP) in the Cytotoxic T lymphocyte antigen-4 gene (CTLA-4) have been associated with several autoimmune diseases including autoimmune Hepatitis (AIH). In this chronic idiopathic inflammatory liver dis